Tech Session III: Nanomedicine and Nanoscale Delivery (Nano)

Chair(s)

• 

  Ronit Satchi-Fainaro, PhD (she/her/hers)

  Professor, PI, Director, Cancer Biology Research Center
  Physiology and Pharmacology
  Tel Aviv University
  Tel Aviv, Tel Aviv, Israel

Co-Chair(s)

• 

  Nathalie Pinkerton, PhD (she/her/hers)

  Assistant Professor
  NYU Tandon School of Engineering
  Brooklyn, New York, United States

Development, physicochemical and biological characterization, in vivo validation, delivery of therapeutics, functionalization with active-targeting moieties, long-acting formulations, controlled release, injectables, implantables. (Focus: Nano)

Presentations:

• 10:04 AM - 10:29 AM EDT

  Invited Speaker Presentation I
  

  Invited Speaker: Daniel Gallego Perez
• 10:29 AM - 10:54 AM EDT

  β-cyclodextrin-based nanomedicines for cancer therapy
  

  Invited Speaker: Anna Scomparin, PhD (she/her/hers) – University of Turin
• 10:54 AM - 11:05 AM EDT

  Lysine-acetylated human serum albumin: enhanced uptake by cancer stem cells and application
  

  Oral Abstract Speaker: Guojun Xiong, PhD (he/him/his) – UCL
• 11:05 AM - 11:16 AM EDT

  Improving Tumor-Specific Drug Delivery: The Role of ADAM17 Inhibition in CD44-Targeted Nanoparticles
  

  Oral Abstract Speaker: sheida Dabiri – university of Pittsburgh
• 11:16 AM - 11:27 AM EDT

  Sustained-Release of Novel Therapies for Treating Opioid Use Disorder
  

  Oral Abstract Speaker: Diane Ingabire (she/her/hers) – Viirginia Commonwealth University
• 11:27 AM - 11:38 AM EDT

  MUC4-Targeted Nanoparticles Deliver MRTX1133 and MDP5 to Overcome Pancreatic Cancer Chemoresistance
  

  Oral Abstract Speaker: Yashwardhan Ghanwatkar – University of Nebraska Medical Center
• 11:49 AM - 12:00 PM EDT

  Local Chapter Speaker Presentation
  

  Local Chapter Speaker: Amirali Popat – School of Pharmacy, The University of Queensland